The patients who accepted the quadruple eradication program of the helicobacter pylori but failed to eradicate helicobacter pylori will be assessed the most suitable re-eradication time of helicobacter pylori.
Helicobacter pylori (HP) infection is a common global infectious disease, which is an important cause of chronic gastritis, peptic ulcer and gastric cancer. At present, due to the non-standard Helicobacter pylori eradication program in clinical work, poor patient compliance and other reasons, the phenomenon of HP eradication treatment failure is more and more common. However, there is still no conclusion on the most appropriate time for remedial treatment in patients with Hp eradication failure.
Study Type
OBSERVATIONAL
Enrollment
820
Esomeprazole-Bismuth-Amoxicillin-Levofloxacin-containing quadruple regimens
Esomeprazole-Bismuth-Amoxicillin-Furazolidone-containing quadruple regimens
Esomeprazole-Bismuth-Tetracycline-Furazolidone-containing quadruple regimens
Qilu Hospital of Shandong University
Jinan, Shandong, China
The most suitable re-eradication time
The most suitable re-eradication time will be assessed by paired comparison method .
Time frame: 1year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Amoxicillin-Levofloxacin-Vonoprazan fumarate-containing quadruple group
Amoxicillin-Furazolidone-Vonoprazan fumarate-containing quadruple group
Tetracycline-Furazolidone-Vonoprazan fumarate-containing quadruple group